Guerrero Ramiro 4
4 · MAIA Biotechnology, Inc. · Filed Feb 25, 2025
Insider Transaction Report
Form 4
Guerrero Ramiro
Director
Transactions
- Purchase
Common Stock
2025-02-24$1.50/sh+73,333$110,000→ 534,885 total - Purchase
Warrants
2025-02-24$1.87/sh+73,333$137,133→ 73,333 totalExercise: $1.87From: 2025-08-24Exp: 2030-08-24→ Common Stock (73,333 underlying)
Footnotes (2)
- [F1]The common stock was purchased pursuant to a Securities Purchase Agreement and were isused under the Issuer's 2021 Equity Incentive Plan on February 24, 2024.
- [F2]These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on February 24, 2024. The options are exercisable beginning on the six month anniversary of the issuance date and expire 5-years after the initial exercise date.